paeonol has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, QH; Li, Q; Ma, SP; Qu, R; Zhong, SZ | 1 |
| Feng, L; Fu, Q; Gu, J; Lan, Z; Liu, J; Ma, D; Ma, S; Qu, R; Song, Y; Wang, S; Zhang, M | 1 |
2 other study(ies) available for paeonol and Cognition Disorders
| Article | Year |
|---|---|
Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Avoidance Learning; Cerebral Cortex; Cognition Disorders; Drugs, Chinese Herbal; Galactose; Glutathione; Hippocampus; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neurodegenerative Diseases; Paeonia; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase | 2009 |
Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.
Topics: Acetophenones; Acetylcholinesterase; Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Caspase 3; Cerebral Cortex; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hippocampus; Insulin-Like Growth Factor I; Male; Maze Learning; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2013 |